Hot
Sema/Cagri
$100.00
- Cagrilintide/GLP-1 (Sema) is a combination peptide formulation designed for investigative use in metabolic and appetite regulation research models. This dual-agent compound includes both a long-acting amylin analog (Cagrilintide) and a GLP-1 (Sema) receptor agonist, facilitating synergistic modulation of satiety and glycemic pathways in preclinical settings.
- This formulation has been studied for its effects on energy homeostasis, gastric emptying, and appetite signaling, offering valuable insights into complex neuroendocrine mechanisms governing caloric intake and metabolic balance.
- Research indicates that the Cagrilintide/GLP-1 (Sema) combination may enhance experimental outcomes in obesity and diabetes models by promoting sustained reductions in food intake and improvements in glucose tolerance.
- Investigators have explored this peptide pairing for its potential to influence body weight regulation, insulin sensitivity, and lipid profiles in animal and cellular models, making it a promising candidate for advanced metabolic research protocols.
- Cagrilintide/GLP-1 (Sema) (5mg/5mg) is intended for laboratory research use only. This compound is ideal for institutions conducting studies on appetite regulation, metabolic disorders, and endocrine signaling.
Overview
Aurex Semaglutide and Cagrilintide Blend is a premium research peptide formulation designed to explore the mechanisms of fat metabolism and weight management. This blend combines two powerful peptides: Semaglutide, known for its appetite-regulating properties, and Cagrilintide, which promotes lipolysis and enhances fat metabolism. Together, they offer a targeted approach to studying metabolic health without the unwanted proliferative effects associated with full growth hormone molecules.
Key Features & Benefits
- Enhanced Metabolic Activity: This blend combines Semaglutide and Cagrilintide, both of which target metabolic pathways to promote fat loss and improve insulin sensitivity, making it a powerful tool in weight management.
- Weight Loss Support: Semaglutide helps regulate appetite and promote satiety, while Cagrilintide aids in fat metabolism, leading to effective weight reduction and improved body composition.
- Muscle Preservation: Unlike many weight loss treatments, this blend supports muscle retention, ensuring that fat loss does not compromise lean muscle mass.
- High-Purity Formulation: Each vial contains a precise blend of Semaglutide and Cagrilintide, maintained at ≥ 99% purity (HPLC verified) for reliable and consistent research outcomes.
- Natural Mechanism: This formulation works through natural pathways in the body, mimicking the action of endogenous hormones to enhance metabolic processes with minimal side effects.
Primary Research Applications
- Weight Management Studies: Used in research examining the efficacy of the Semaglutide and Cagrilintide blend in promoting weight loss and metabolic health.
- Muscle Preservation Research: Investigates how this blend aids in maintaining muscle integrity during weight loss protocols.
- Metabolic Function Studies: Explores the interaction of the blend with various metabolic pathways and hormones in the body.
- Comparative Analysis: Allows for evaluation of the effects of Semaglutide and Cagrilintide against traditional weight loss agents in clinical and experimental settings.
Product Specifications
- Unit Size: 10mg (5mg/5mg)
- Compounds: Semaglutide and Cagrilintide
- Purity: ≥ 99% purity (HPLC verified) for assured consistency in research results
- Quantity: Provided in research-grade amounts per vial for experimental flexibility
- Form: Lyophilized (freeze-dried) powder for stability and convenience in laboratory settings
- Storage: Store in a cool, dry place. For long-term stability, refrigeration is recommended.
Reviews
There are no reviews yet.